CAISHA WILLIAMS: Open Payments
NPI 1386480663 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 23 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $213 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $266 |
| ABBVIE INC. | 2 | $141 |
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
| Indivior Inc. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Lundbeck LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: INGREZZA, VRAYLAR, REXULTI, SUBLOCADE, COBENFY, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
